Additional multiplex immunostaining experiments to include beta cell identity and endocrine cell markers [42, 43], and islet hormone processing products (such as amidated GLP-1), could be used to unfold the fluidity of islet cell fates during development of diabetes. The gene discussed is GCG; the disease is diabetes mellitus.